Perceived cognitive dysfunction in fibromyalgia syndrome

Journal of Musculoskeletal Pain

Volumn 19, Issue 2, 2011, Pages 66-75

  Williams, David A ^a   Clauw, Daniel J ^a   Glass, Jennifer M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

brain fog; chronic pain; dyscognition; fibro fog; Fibromyalgia syndrome

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DYSPNEA; FEMALE; FIBROMYALGIA; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MOOD; MULTIPLE ABILITIES SELF REPORT QUESTIONNAIRE; PAIN; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; SELF REPORT; SLEEP DISORDER; SNORING; SOMNOLENCE; VERBAL MEMORY; VISION;

EID: 79953043256     PISSN: 10582452     EISSN: 15407012     Source Type: Journal    
DOI: 10.3109/10582452.2011.558989     Document Type: Article

References (41)

1. Raspe H, Baumgartner C, Wolfe F: The prevalence of fibromyal-gia in a rural German community: how much difference do different criteria make? Arthritis Rheum 36: S48, 1993.
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The preva-lence and characteristics of fibromyalgia in the general popu-lation. Arthritis Rheum 38: 19-28, 1995.
3. Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL: Evaluating and diagnosing fibromyalgia and comorbid psychia-tric disorders. J Clin Psychiatry 69: e28, 2008.
4. Rutledge DN, Mouttapa M, Wood PB: Symptom clusters in fi-bromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res 58: 359-367, 2009.
5. Glass JM: Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control im-pairments. Rheum Dis Clin North Am 35: 299-311, 2009.
6. Katz RS, Heard AR, Mills M, Leavitt F: The prevalence and clini-cal impact of reported cognitive difficulties (Fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 10: 53-58, 2004. (Pubitemid 38496092)
7. Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Patient perspectives on the impact of fibro-myalgia. Patient Educ Couns 73: 114-120, 2008.
8. Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Wil-liams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ: Fibro-myalgia syndrome. J Rheumatol 32: 2270-2277, 2005.
9. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 59: 952-960, 2008. (Pubitemid 351990991)
10. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L: An inter-net survey of 2,596 people with fibromyalgia. BMC Musculoske-let Disord 8: 27, 2007.
11. Glass JM, Park DC, Minear M, Crofford LJ: Memory beliefs and function in fibromyalgia patients. J.Psychosom Res 58: 263-269, 2005. (Pubitemid 40603914)
12. Dick BD, Verrier MJ, Harker KT, Rashiq S: Disruption of cognitive function in fibromyalgia syndrome. Pain 139 (3): 610-616, 2008.
13. Nicholson K, Martelli MF, Zasler ND: Does pain confound interpretation of neuropsychological test results? NeuroRehabil-itation 16: 225-230, 2001. (Pubitemid 34063085)
14. Dick BD, Verrier MJ, Harker KT, Rashiq S: Disruption of cogni-tive function in fibromyalgia syndrome. Pain 139: 610-616, 2008.
15. Barsevick AM: The concept of symptom cluster. Semin Oncol Nurs 23: 89-98, 2007.
16. Suhr JA: Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 55: 321-329, 2003. (Pubitemid 38367756)
17. Grace GM, Nielson WR, Hopkins M, Berg MA: Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21: 477-487, 1999.
18. Landro NI, Stiles TC, Sletvold H: Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42: 297-306, 1997. (Pubitemid 27186881)
19. Sephton SE, Studts JL, Hoover K, Weissbecker I, Lynch G, Ho I, McGuffin S, Salmon P: Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 22: 592-597, 2003. (Pubitemid 37466947)
20. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Arthritis Rheum 33: 160-172, 1990.
21. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A: Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 16: 93-104, 1994. (Pubitemid 24051080)
22. Martin R, Griffith HR, Sawrie S, Knowlton R, Faught E: Determining empirically based self-reported cognitive change: development of reliable change indices and standardized regression-based change norms for the Multiple Abilities Self-Report Questionnaire in an epilepsy sample. Epilepsy Behav 8: 239-245, 2006. (Pubitemid 43103854)
23. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA: Brain struc-ture and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25: 3866-3870, 2007. (Pubitemid 47477262)
24. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH: The efficacy and safety of milnacipran for treat-ment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 36: 398-409, 2009.
25. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y: Milna-cipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30: 1988-2004, 2008.
26. Piasecki TM, Hufford MR, Solhan M, Trull TJ: Assessing clients in their natural environments with electronic diaries: rationale, benefits, limitations, and barriers. Psychol Assess 19: 25-43, 2007. (Pubitemid 46440642)
27. Williams DA, Gendreau M, Hufford MR, Groner K, Gracely RH, Clauw DJ: Pain assessment in patients with fibromyalgia syndrome: a consideration of methods for clinical trials. Clin J Pain 20: 348-356, 2004. (Pubitemid 39108848)
28. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic cri-teria for fibromyalgia and measurement of symptom severity Arthritis Care Res 62: 600-610, 2010.
29. Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimen-sional Fatigue Inventory (MFI) psychometric qualities of an in-strument to assess fatigue. J Psychosom Res 39: 315-325, 1995.
30. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974-2984, 2004. (Pubitemid 39209537)
31. Stewart AL, Ware JE: Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Duke University Press, Durham, NC, 1992.
32. Sadosky A, Dukes E, Evans C: Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia. Health Qual Life Outcomes 7: 12, 2009.
33. Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S: Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibro-myalgia. Sleep Med 10: 766-770, 2009.
34. Spielberger CD, Reheiser EC: Assessment of emotions: anger, anxiety, depression, and curiosity Appl Psychol: Health Well-being 1: 271-302, 2009.
35. Spielberger CD: STAXI-2: State-Trait Anger Expression Inven-tory-2. Professional Manual. Psychological Assessment Re-sources (PAR), Inc., Odessa, FL, 1999.
36. Spielberger CD, Gorsuch, RC, Lushene RE, Vagg PR Manual for the State-Trait Anxiety Inventory (Form Y): ("Self-evaluation questionnaire"). Consulting Psychologists, Palo Alto, CA, 1983.
37. Williams DA, Schilling S: Advances in the assessment of fibro-myalgia. Rheum Dis Clin North Am 35: 339-357, 2009.
38. Mease PJ, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA: Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 36: 2318-2329, 2009.
39. Hertzog C, Lineweaver TT, McGuire CL: Beliefs about memory and aging. Social Cognition and Aging. Edited by Hess TM. Academic Press, San Diego, 1999, pp. 43-68.
40. Park DC, Glass JM, Minear M, Crofford LJ: Cognitive func-tion in fibromyalgia patients. Arthritis Rheum 44: 2125-2133, 2001.
41. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL: The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11: R120, 2009.